Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan...

29
Standardising The Standards: The Benefits of Consistency Nathan James, Roche Products Ltd.

Transcript of Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan...

Page 1: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Standardising The Standards: The Benefits of Consistency

Nathan James, Roche Products Ltd.

Page 2: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

SDTMs – An End User’s Perspective

ü  Improved submission of clinical data to Regulators

ü  Improved transmission of clinical data between CRO and Sponsor

Is the implementation of the SDTM model always the

same?

CLAIM:

The interpretation and implementation of the model can vary between companies

Page 3: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

A Simple Analogy

“Bring me a standard red apple!”

Page 4: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

•  SDTM build was outsourced for the project

•  2 studies had the SDTM construction with 2 different vendors

•  Future pooling of studies likely

•  Assumed standard framework and structure, regardless of who was constructing the SDTMs.

Background

Project

Study 1 Study 2

Vendor 1 Vendor 2

Page 5: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

The Reality

•  SDTMs differed in a variety of ways

•  2 categories: –  Expected differences –  Unexpected differences

Page 6: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Expected Differences

•  There will always be expected differences

•  Based on the similarity of the collected data

•  Safety domains more comparable than efficacy domains

Page 7: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Expected Differences

1.  Domains delivered

2.  Study specific elements

3.  Trial Design Domains

4.  SDTM Versions

Page 8: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Expected Differences

TA TE TI

TS TV

TA TE TI

TS TV

DS DM

AE EX

LB

DS DM

AE EX

LB

STUDY 1 STUDY 2

QS ZA RS TR

Page 9: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Expected Differences

1.  Domains delivered

2.  Study specific elements

3.  Trial Design Domains

4.  SDTM Versions

Page 10: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Expected Differences

1.  Domains delivered

2.  Study specific elements

3.  Trial Design Domains

4.  SDTM Versions

Page 11: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Expected Differences

1.  Domains delivered

2.  Study specific elements

3.  Trial Design Domains

4.  SDTM Versions

Page 12: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Unexpected Differences

1.  Subjective interpretations of the model

2.  Mapping decisions

Page 13: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Unexpected Differences

•  Related to derivations performed within the model –  Trial Design Domains –  Exposure domain

•  Input from an analysis perspective –  Reference start date [DM.RFSTDTC] –  Baseline flags [--BLFL]

Page 14: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Unexpected Differences

1.  Subjective interpretations of the model

2.  Mapping decisions

Page 15: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Unexpected Differences

•  Data that has no obvious mapping into the model –  Deaths collected as an event

Page 16: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Unexpected Differences

AE.AEDTHDTC

AE.AETERM

CE.CESTDTC

CE.CETERM

DS.DSSTDTC

DS.DSDECOD = ‘DEATH’

Page 17: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Unexpected Differences

•  Data that has no obvious mapping into the model –  Deaths collected as an event –  Non-standard elements

•  No right or wrong way of mapping some data –  Different vendors take different approaches

Page 18: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Automated Checking Tool

•  Extent of the differences was unknown

•  Automated tool to check for discrepancies developed

•  More benefits to the tool than first perceived

Page 19: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Automated Checking Tool

ü List all discrepancies between 2 sets of SDTM data

ü Focus on consistency of tabulation and not conformance

ü Dynamic

ü Simple to use

REQUIREMENTS

Page 20: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Automated Checking Tool

DOMAIN CHECK

•  Checks differences in the existence of domains

STUDY 1 (xx11111) STUDY 2 (xx22222)

DA SE

XP

Page 21: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Automated Checking Tool

VARIABLE CHECK

•  Checks differences in the variables – existence and attributes

•  Only common domains compared

STUDY 1 (xx11111) STUDY 2 (xx22222)

AE AE?

AE.AEDECOD? AE.AEDECOD

Label Format

Length Type

Informat

Label Format

Length Type

Informat

Page 22: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Automated Checking Tool

Page 23: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Automated Checking Tool

VALUE CHECK

•  Checks differences in the controlled terminology

•  Values checked only on common variables on common domains

•  List of variables to be excluded added to the macro

Page 24: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Automated Checking Tool

VALUE CHECK

•  Current tool runs better on events and intervention domains

→ all observations considered for each variable

•  Findings domains are more problematic

→ checks not performed on a parameter level

•  Possible future enhancement of the tool.

Page 25: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Tool Benefits

ü Time/cost saving over manual checks

ü Datasets more consistent →  Improved  pooling  poten0al  

ü Run at start of a study →  Pooling  considered  early    

           →  No  impact  on  analysis  programs    

ü Run  of  an  individual  study  →  monitor  mapping/data  changes  

ü Development  of  standard  programs  and  maintenance  →  targeted  

Page 26: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Tool Benefits

STUDY 1 STUDY 2

LB.LBMETHOD: PHOTOGRAPH PHOTOGRAPH

Standard/Project Program extract:

STUDY 3

PHOTOGRAPHY

LB.LBMETHOD:

Known new term in LBMETHOD → Search for programs containing LBMETHOD

Page 27: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Tool Benefits

ü Time/cost saving over manual checks

ü Datasets more consistent →  Improved  pooling  poten0al  

ü Run at start of a study →  Pooling  considered  early    

           →  No  impact  on  analysis  programs    

ü Run  of  an  individual  study  →  monitor  mapping/data  changes  

ü Development  of  standard  programs  and  maintenance  →  targeted  

ü Extends  to  Analysis  Datasets  or  SDTMs  constructed  on  different  versions  of  the  model  

Page 28: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Conclusion

•  Plan for pooling activities early

•  More consistent SDTMs →  beEer  pooling  &  standard  programs  

•  Develop an automated tool

•  Further benefits to this tool than just SDTM consistency

•  Why do these differences exist?

•  Never assume SDTMs will be structurally identical

Page 29: Nathan James, Roche Products Ltd. - Lex Jansen › phuse › 2013 › dh › DH06_ppt.pdf · Nathan James, Roche Products Ltd. SDTMs – An End User’s Perspective ... • Future

Doing now what patients need next